The Bone Morphogenetic Protein Pathway: The Osteoclastic Perspective

Bone health crucially relies on constant bone remodeling and bone regeneration, both tightly controlled processes requiring bone formation and bone resorption. Plenty of evidence identifies bone morphogenetic proteins (BMP) as major players in osteoblast differentiation and thus, bone formation. However, in recent past years, researchers also increasingly reported on the pivotal role of these multi-functional growth factors in osteoclast formation and activity. This review aims to summarize the current knowledge of BMP signaling within the osteoclast lineage, its role in bone resorption, and osteoblast–osteoclast coupling. Furthermore, subsequent clinical implications for recombinant BMP therapy will be discussed in view of recent preclinical and clinical studies.

[1]  J. Köhrle,et al.  Disruption of BMP Signaling Prevents Hyperthyroidism‐Induced Bone Loss in Male Mice , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  B. Alman,et al.  Erythromyeloid progenitors give rise to a population of osteoclasts contributing to bone homeostasis and repair , 2019, Nature Cell Biology.

[3]  V. Kaartinen,et al.  Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway , 2019, The Journal of Biological Chemistry.

[4]  Claudia Waskow,et al.  Developmental origin, functional maintenance and genetic rescue of osteoclasts , 2019, Nature.

[5]  F. Bosch,et al.  BMP4 Gene Therapy Inhibits Myeloma Tumor Growth, but Has a Negative Impact on Bone , 2018, Blood.

[6]  V. Rosen,et al.  The BMP Pathway and Its Inhibitors in the Skeleton. , 2018, Physiological reviews.

[7]  S. Vukicevic,et al.  Bone morphogenetic proteins in fracture repair , 2018, International Orthopaedics.

[8]  R. Gopalakrishnan,et al.  SMAD1/5 signaling in osteoclasts regulates bone formation via coupling factors , 2018, PloS one.

[9]  Y. Mishina,et al.  Pharmacologic Calcitriol Inhibits Osteoclast Lineage Commitment via the BMP‐Smad1 and IκB‐NF‐κB Pathways , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  H. Aburatani,et al.  Smad4 is required to inhibit osteoclastogenesis and maintain bone mass , 2016, Scientific Reports.

[11]  Olumide O. Aruwajoye,et al.  Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength. , 2016, Bone.

[12]  Yi-Ping Li,et al.  TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease , 2016, Bone Research.

[13]  K. Lyons,et al.  Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors , 2016, Scientific Reports.

[14]  S. Khosla,et al.  Osteoclast TGF‐β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  S. Cummings,et al.  Postmenopausal osteoporosis , 2016, Nature Reviews Disease Primers.

[16]  C. Billington,et al.  The Function of Twisted Gastrulation in Regulating Osteoclast Differentiation is Dependent on BMP Binding , 2015, Journal of cellular biochemistry.

[17]  B. Huang,et al.  Smad1/5 and Smad4 Expression Are Important for Osteoclast Differentiation , 2015, Journal of cellular biochemistry.

[18]  Louis C. Gerstenfeld,et al.  Fracture healing: mechanisms and interventions , 2015, Nature Reviews Rheumatology.

[19]  J. Charles,et al.  Osteoclasts: more than 'bone eaters'. , 2014, Trends in molecular medicine.

[20]  S. Vukicevic,et al.  Systemically available bone morphogenetic protein two and seven affect bone metabolism , 2014, International Orthopaedics.

[21]  B. Yu,et al.  BMP-2 and titanium particles synergistically activate osteoclast formation , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  S. Vukicevic,et al.  The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing , 2014, International Orthopaedics.

[23]  H. Beppu,et al.  Bone Morphogenetic Proteins Signal Via SMAD and Mitogen-activated Protein (MAP) Kinase Pathways at Distinct Times during Osteoclastogenesis* , 2013, The Journal of Biological Chemistry.

[24]  H. Isaksson,et al.  Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model. , 2013, Bone.

[25]  T. He,et al.  BMP signaling in mesenchymal stem cell differentiation and bone formation. , 2013, Journal of biomedical science and engineering.

[26]  Arpita Tiwari,et al.  Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Spine Fusion , 2013, Annals of Internal Medicine.

[27]  Mark C Simmonds,et al.  Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion , 2013, Annals of Internal Medicine.

[28]  Gino Laberge,et al.  Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro. , 2013, Cellular signalling.

[29]  M. McDonald,et al.  Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength , 2013, Acta orthopaedica.

[30]  U. Lerner,et al.  Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2. , 2013, Bone.

[31]  G. Hänsch,et al.  Inhibition of Osteoclast Generation: A Novel Function of the Bone Morphogenetic Protein 7/Osteogenic Protein 1 , 2012, Mediators of inflammation.

[32]  M. Bouxsein,et al.  A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength , 2012, Proceedings of the National Academy of Sciences.

[33]  Y. Mishina,et al.  Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  Hiroshi Tsumura,et al.  Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model. , 2011, Bone.

[35]  J. Mönkkönen,et al.  Biochemical and molecular mechanisms of action of bisphosphonates. , 2011, Bone.

[36]  G. Flivik,et al.  Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density , 2011, Acta orthopaedica.

[37]  Masato Yamamoto,et al.  Bone morphogenetic protein 2 signaling in osteoclasts is negatively regulated by the BMP antagonist, twisted gastrulation , 2011, Journal of cellular biochemistry.

[38]  Y. Miyamoto,et al.  Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts , 2010, Cell and Tissue Research.

[39]  H. Seeherman,et al.  rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. , 2010, The Journal of bone and joint surgery. American volume.

[40]  J. Westendorf,et al.  Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors , 2010, Journal of cellular biochemistry.

[41]  B. MacKenzie,et al.  Enhanced Osteoclastogenesis Causes Osteopenia in Twisted Gastrulation‐Deficient Mice Through Increased BMP Signaling , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  S. Khosla,et al.  Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate , 2008, Proceedings of the National Academy of Sciences.

[43]  D. J. Lucas,et al.  Disruption of BMP Signaling in Osteoblasts Through Type IA Receptor (BMPRIA) Increases Bone Mass , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  Tamara Sztynda,et al.  Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. , 2008, Bone.

[45]  Aaron Schindeler,et al.  Bone remodeling during fracture repair: The cellular picture. , 2008, Seminars in cell & developmental biology.

[46]  P. Aspenberg,et al.  Manipulating the anabolic and catabolic response in bone graft remodeling: Synergism by a combination of local BMP‐7 and a single systemic dosis of zoledronate , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[47]  C. Court-Brown,et al.  A comparison of RhBMP-7 (OP-1) and autogenous graft for metaphyseal defects after osteotomy of the distal radius. , 2008, Injury.

[48]  H. Anderson,et al.  Expression and Synthesis of Bone Morphogenetic Proteins by Osteoclasts: A Possible Path to Anabolic Bone Remodeling , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[49]  R. O’Keefe,et al.  Murine and Chicken Chondrocytes Regulate Osteoclastogenesis by Producing RANKL in Response to BMP2 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  H. Takayanagi The Role of NFAT in Osteoclast Formation , 2007, Annals of the New York Academy of Sciences.

[51]  Hong-Hee Kim,et al.  Sphingosine 1‐phosphate as a regulator of osteoclast differentiation and osteoclast–osteoblast coupling , 2006, The EMBO journal.

[52]  H. Yoshikawa,et al.  Bone Morphogenetic Proteins in Bone Stimulate Osteoclasts and Osteoblasts During Bone Development , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  F. Watzinger,et al.  Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation , 2006 .

[54]  C. Wan,et al.  Osteoclastogenesis in the nonadherent cell population of human bone marrow is inhibited by rhBMP‐2 alone or together with rhVEGF , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[55]  N. Amanat,et al.  Manipulation of the Anabolic and Catabolic Responses With OP‐1 and Zoledronic Acid in a Rat Critical Defect Model , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[56]  L. Hofbauer,et al.  The OPG/RANKL/RANK system in metabolic bone diseases. , 2004, Journal of musculoskeletal & neuronal interactions.

[57]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[58]  T. Glant,et al.  Osteolysis: basic science. , 2001, Clinical orthopaedics and related research.

[59]  D. Howie,et al.  The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. , 2001, The Journal of bone and joint surgery. British volume.

[60]  N. Ueno,et al.  Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand. , 2001, Endocrinology.

[61]  M. Longaker,et al.  Expression of bone morphogenetic proteins during membranous bone healing. , 2001, Plastic and reconstructive surgery.

[62]  H. Anderson,et al.  Bone Morphogenetic Protein (BMP) Localization in Developing Human and Rat Growth Plate, Metaphysis, Epiphysis, and Articular Cartilage , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[63]  M. Kumegawa,et al.  Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. , 2000, Bone.

[64]  S. Teitelbaum,et al.  Bone resorption by osteoclasts. , 2000, Science.

[65]  R. Jilka,et al.  Essential Requirement of BMPs‐2/4 for Both Osteoblast and Osteoclast Formation in Murine Bone Marrow Cultures from Adult Mice: Antagonism by Noggin , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[66]  K. Kusumoto,et al.  Comparison of recombinant and purified human bone morphogenetic protein. , 1999, The British journal of oral & maxillofacial surgery.

[67]  M. Laursen,et al.  Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results , 1999, European Spine Journal.

[68]  B. Riggs,et al.  Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. , 1998, Biochemical and biophysical research communications.

[69]  K. Chihara,et al.  Stimulatory effect of bone morphogenetic protein‐2 on osteoclast‐like cell formation and bone‐resorbing activity , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[70]  P. Lehenkari,et al.  Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption. , 1995, Biochemical and biophysical research communications.

[71]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[72]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.